The purpose of this study is to test whether adding 4 injections of rituximab and increasing
the intensity of chemotherapy regimens in advanced patients can improve the EFS compared with
the historical study CCCG-NHL-2010.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Children's Cancer Group, China
Collaborators:
Children's Hospital Of Soochow University Children’s Hospital of Sochow University, China Nanjing Children's Hospital Qilu Hospital Qilu Hospital of Shandong University Tianjin Medical University Cancer Institute and Hospital Tongji Hospital Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, China West China Second University Hospital Xiangya Hospital of Central South University